Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 10.27 SEK 0.2% Market Closed
Market Cap: 500.3m SEK

Intrinsic Value

The intrinsic value of one MOB stock under the Base Case scenario is 7.09 SEK. Compared to the current market price of 10.27 SEK, Moberg Pharma AB (publ) is Overvalued by 31%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MOB Intrinsic Value
7.09 SEK
Overvaluation 31%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Moberg Pharma AB (publ)

What is Valuation History?
Ask AI Assistant
What other research platforms think about MOB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MOB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Moberg Pharma AB (publ).

Explain Valuation
Compare MOB to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MOB?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Moberg Pharma AB (publ)

Current Assets 249.5m
Cash & Short-Term Investments 236.2m
Receivables 8.2m
Other Current Assets 5m
Non-Current Assets 444.2m
PP&E 3.2m
Intangibles 342.6m
Other Non-Current Assets 98.4m
Current Liabilities 15.5m
Other Current Liabilities 15.5m
Non-Current Liabilities 1.3m
Long-Term Debt 1.3m
Efficiency

Free Cash Flow Analysis
Moberg Pharma AB (publ)

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Moberg Pharma AB (publ)

Revenue
12.5m SEK
Cost of Revenue
-6m SEK
Gross Profit
6.5m SEK
Operating Expenses
-334.5m SEK
Operating Income
-328m SEK
Other Expenses
70.2m SEK
Net Income
-257.8m SEK
Fundamental Scores

MOB Profitability Score
Profitability Due Diligence

Moberg Pharma AB (publ)'s profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Operating Margin is Increasing
Strong 3Y Average Gross Margin
Net Margin is Increasing
20/100
Profitability
Score

Moberg Pharma AB (publ)'s profitability score is 20/100. The higher the profitability score, the more profitable the company is.

MOB Solvency Score
Solvency Due Diligence

Moberg Pharma AB (publ)'s solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
75/100
Solvency
Score

Moberg Pharma AB (publ)'s solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MOB Price Targets Summary
Moberg Pharma AB (publ)

Wall Street analysts forecast MOB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOB is 13.26 SEK with a low forecast of 13.13 SEK and a high forecast of 13.65 SEK.

Lowest
Price Target
13.13 SEK
28% Upside
Average
Price Target
13.26 SEK
29% Upside
Highest
Price Target
13.65 SEK
33% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Moberg Pharma AB (publ)
does not pay dividends
Shareholder Yield

Current shareholder yield for MOB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one MOB stock?

The intrinsic value of one MOB stock under the Base Case scenario is 7.09 SEK.

Is MOB stock undervalued or overvalued?

Compared to the current market price of 10.27 SEK, Moberg Pharma AB (publ) is Overvalued by 31%.

Back to Top